MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • 2024 International Congress

    Common Genotypes Of Dystonia and Response To DBS; Tertiary Center Experience

    A. Aldakheel, H. Alhodaif, Y. Alkhodair, H. Alfaris (Riaydh, Saudi Arabia)

    Objective: This study aims to evaluate the impact of deep brain stimulation (DBS) on monogenic dystonia. Background: Monogenic dystonia is a heterogenic group of disorders…
  • 2024 International Congress

    Movement Disorder Presentations in Leukoenephalopathy with Calcifications and Cysts

    L. Tochen, J. Harmon, J. Rhee, J. Fraser (Washington, USA)

    Objective: The aim of this study is to describe the movement disorder phenotypes within a cohort of individuals with Leukoencephalopthy with Calcifications and Cysts. Background:…
  • 2024 International Congress

    Longitudinal Assessment of Dystonic Symptoms in Rapid-Onset Dystonia-Parkinsonism: genetic dystonia symptoms vary over time

    I. Haq, V. Wheelock, L. Ozelius, B. Snively, E. Napoli, K. Sweadner, A. Brashear (Miami, USA)

    Objective: To clarify the temporal progression of symptoms in the rare genetic dystonia, ATP1A3 disease Background: The ATP1A3 gene encodes the neuronally ubiquitous α3 subunit…
  • 2024 International Congress

    Autosomal Recessive GTPCH Deficiency: Redefining the Phenotypic Spectrum and Outcome

    M. Novelli, M. Tolve, V. Quiroz, C. Carducci, R. Bove, G. Ricciardi, C. Yang, F. Pisani, D. Ebrahimi-Fakhari, S. Galosi, V. Leuzzi (Rome, Italy)

    Objective: To describe the clinical phenotype of autosomal recessive GTP cyclohydrolase deficiency (ARGTPCHD), its genetic and metabolic correlates, and their possible predictive value through a…
  • 2024 International Congress

    Challenges in Wilson disease management in a resource-limited country: a case report from a tertiary center

    M. Soares, M. Santiago, A. Simeão, H. Galvão, P. Fontana, F. Travassos, M. Ramalho, R. Mendonça (Recife, Brazil)

    Objective: To describe a Wilson disease (WD) case report with severe neurological manifestations who was successfully treated with zinc salt monotherapy, due to unavailability of…
  • 2024 International Congress

    Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient

    M. Danis, G. Krastev, J. Necpal, R. Jech, M. Zech (Trnava, Slovakia)

    Objective: We present a patient with generalized dystonia with spasticity, craniofacial dysmorphism and myoclonus on the left upper limb due to mutation of the ATP5F1A…
  • 2024 International Congress

    A 24-year-old female with 18p deletion syndrome presenting with rapidly worsening dystonia

    P. Hoang, T. Stiep (San Francisco, USA)

    Objective: To describe a case of rapidly worsening dystonia in 18p deletion syndrome. Background: 18p deletion syndrome resulting from deletion of the short arm of…
  • 2024 International Congress

    Unraveling the Complexity of Neurodegenerative Disorders: A Case Report of PKAN Suspected in a 24-Year-Old Patient with Severe Dystonia

    L. Kenjaeva, B. Mukhammedaminov, R. Abdukakhkhorova (Tashkent, Uzbekistan)

    Objective: To present a case study of a 24-year-old patient with severe dystonia and cognitive decline, suspected to have Pantothenate Kinase-Associated Neurodegeneration (PKAN), a rare subtype…
  • 2024 International Congress

    The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

    K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

    Objective: ​​​​​​Childhood-onset Huntington’s disease (HD) is a rare subset of HD with symptom-onset before the age of 18 years. We here detail the presenting movement…
  • 2024 International Congress

    Startle Reflex in CTNNB1 Mutations: A diagnostic Clue

    S. Nagaratnam, D. Wilson, M. Garcia, J. Qiu, D. Hadi, S. Mohammad, H. Morales Briceno (Westmead, Australia)

    Objective: To describe two patients with CTNNB1 mutation with a startle reflex, an underrecognised clinical sign. Background: CTNNB1 mutations is an increasingly recognised cause of…
  • 1
  • 2
  • 3
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley